Cargando…

A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study

BACKGROUND: The HIV-1 DNA reservoir is an important marker that reflects viro-immunological status and can be affected by multiple viral or cellular factors. Determining the potential factors associated with the size of the HIV-1 DNA reservoir benefits the surveillance of disease progression and ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Yongsong, Wang, Nidan, Han, Yang, Zhu, Ting, Xie, Jing, Qiu, Zhifeng, Song, Xiaojing, Li, Yanling, Routy, Jean-Pierre, Wang, Jianhua, Li, Taisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732419/ https://www.ncbi.nlm.nih.gov/pubmed/29246197 http://dx.doi.org/10.1186/s12879-017-2866-y

Ejemplares similares

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients
por: Lu, Wei, et al.
Publicado: (2015)

Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients
por: Lu, Wei, et al.
Publicado: (2018)

Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era
por: Cao, Wei, et al.
Publicado: (2016)

The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study
por: Luo, Ling, et al.
Publicado: (2019)

Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients
por: Han, Yang, et al.
Publicado: (2015)

HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive antiretroviral therapy
por: Zhu, Tianyuan, et al.
Publicado: (2023)

Gut lactate-producing bacteria promote CD4 T cell recovery on Anti-retroviral therapy in HIV-infected patients
por: Lyu, Wei, et al.
Publicado: (2021)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy
por: Li, Xiuxia, et al.
Publicado: (2023)

Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects
por: Li, Yijia, et al.
Publicado: (2016)

Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study
por: Yue, Yongsong, et al.
Publicado: (2021)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
por: Leung, Victor, et al.
Publicado: (2013)

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016)

CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy
por: Okhai, Hajra, et al.
Publicado: (2020)

CD4(+) T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
por: Li, Xiaodi, et al.
Publicado: (2023)

Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study
por: Lee, Shui Shan, et al.
Publicado: (2017)

Ultralow Threshold Room Temperature Polariton Condensation in Colloidal CdSe/CdS Core/Shell Nanoplatelets
por: Yang, Hongyu, et al.
Publicado: (2022)

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort
por: Li, Taisheng, et al.
Publicado: (2008)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

The predictive role of CD4(+) cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China
por: Li, Chong-Xi, et al.
Publicado: (2019)

Higher CD27(+)CD8(+) T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4(+) T Cell Recovery in Treated HIV Infection
por: Seu, Lillian, et al.
Publicado: (2013)

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study
por: De Salvador-Guillouët, F., et al.
Publicado: (2015)

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
por: Gras, Luuk, et al.
Publicado: (2019)

Naïve CD4(+) cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk
por: Menozzi, Marianna, et al.
Publicado: (2014)

Profiling of coexpression of multiple immune checkpoints in the CD4+ and CD8+ T cell components of the clear cell renal cell carcinoma immune infiltrate
por: Monette, Anne, et al.
Publicado: (2015)

Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults
por: Qin, Ling, et al.
Publicado: (2016)

Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease
por: Guo, Fuping, et al.
Publicado: (2017)

Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: Han, Jingqi, et al.
Publicado: (2022)

Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade
por: Wolday, Dawit, et al.
Publicado: (2020)

Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study
por: Hema, Mariam Noelie, et al.
Publicado: (2016)

CD3(+)T, CD4(+)T, CD8(+)T, and CD4(+)T/CD8(+)T Ratio and Quantity of γδT Cells in Peripheral Blood of HIV-Infected/AIDS Patients and Its Clinical Significance
por: Zhao, Nange, et al.
Publicado: (2021)

The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article
por: YIN, Yongmei, et al.
Publicado: (2015)

Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
por: Lee, Po-Hsin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4hm09km085r4i1tbfme05ibt32